title: Therapy of hyperlipidemia with lovastatin in kidney transplant patients on cyclosporine A immunosuppression: three-year experience.
authors.affiliation: Department of Nephrology, University Medical Centre, Ljubljana, Slovenia.
authors.forename: A
authors.initials: A
authors.lastname: Kandus
authors.forename: D
authors.initials: D
authors.lastname: Kovac
authors.forename: D
authors.initials: D
authors.lastname: Cerne
authors.forename: M
authors.initials: M
authors.lastname: Koselj
authors.forename: S
authors.initials: S
authors.lastname: Kaplan-Pavlovcic
authors.forename: J
authors.initials: J
authors.lastname: Buturović
authors.forename: R
authors.initials: R
authors.lastname: Ponikvar
authors.forename: R
authors.initials: R
authors.lastname: Kveder
authors.forename: J
authors.initials: J
authors.lastname: Lindic
authors.forename: A F
authors.initials: AF
authors.lastname: Bren
mesh_terms: D000328:Adult; D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D004576:Electromyography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000209:etiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008148:Lovastatin / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012206:Rhabdomyolysis / Q000139:chemically induced
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D002784:Cholesterol; D008148:Lovastatin